This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


GlaxoSmithKline plc

Drug Names(s): GW695634

Description: GW695634, a novel next generation non-nucleoside reverse transcriptase inhibitor (NNRTI), is a pro-drug of GW678248 that had been demonstrated in tissue culture to display potent antiviral activity against both wild-type HIV-1 as well as viruses containing a variety of NNRTI-associated mutations, including both K103N and Y181C.

Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug